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OBJECTIVES We sought to evaluate myocardial viability (inotropic reserve) after myocardial infarction
(MI) and its relationship with the presence of unstable pre-infarction angina (PIA).
BACKGROUND Several studies have suggested that PIA can limit infarct size, but it is not known whether
PIA can elicit myocardial viability after an acute MI, with left ventricular function
improvement.
METHODS Before discharge from the hospital, 91 patients with a reperfused MI (either fibrinolysis or
primary coronary angioplasty) had low-dose dobutamine echocardiography performed to
assess the myocardial inotropic reserve of the infarct-related area.
RESULTS Twenty-nine patients (31.9%) had PIA in the 24-h period before the onset of MI. Nine
patients were treated with primary coronary angioplasty: five (8.1%) in the group with PIA
and four (13.8%) in the group without PIA. There were no other significant differences in the
baseline characteristics of the patients. There were more viable segments in patients with PIA
(44.9% vs. 30.7%, p 5 0.007), and the number of patients with significant viability was higher
in the PIA group (73.9% vs. 46.3%, p 5 0.026). This occurred despite a similar number of
segments with segmental wall abnormalities at baseline in both groups (46.1% vs. 46.9%, p 5
NS).
CONCLUSIONS The presence of previous unstable PIA induces greater myocardial viability of the infarct-
related area upon reperfusion and, as such, could have considerable therapeutic and clinical
implications. (J Am Coll Cardiol 2001;37:1846–50) © 2001 by the American College of
Cardiology
Brief periods of myocardial ischemia before the onset of an
acute myocardial infarction (MI) can delay cell death (1–3),
thus preserving regional and global left ventricular function
(4–6). The use of fibrinolytic therapy and primary coronary
angioplasty has become widespread recently, and data on
left ventricular function in this setting have been variable:
some studies have indicated improved left ventricular func-
tion in patients with pre-infarction angina (PIA) (7,8),
whereas others have suggested only a marginal benefit
(3,9,10), and yet others have indicated that this benefit is
restricted to very specific groups of patients (11–13). Re-
cently, for example, Ishihara et al. (13) confirmed the data of
Abete et al. (11) on the absence of a beneficial effect of
prodromal angina in elderly patients, and, more impor-
tantly, it was found that the protective effect of prodromal
angina is lost in these patients at five years of follow-up.
The present study was designed to prospectively assess
the effects of the presence of unstable angina, before the
onset of an acute MI, on regional and global left ventricular
function and on myocardial inotropic reserve (extent of
viable myocardium) in the region of the jeopardized ventri-
cle. The objective was to identify those patients who would
benefit most from this myocardial preconditioning effect.
METHODS
Patients. We selected all patients diagnosed as having had
an acute MI lasting ,12 h and who had been treated with
either fibrinolytic drugs or primary coronary angioplasty.
Myocardial infarction was diagnosed when the following
criteria were fulfilled: 1) typical chest pain lasting .30 min;
2) ST segment elevation of at least 0.2 mV in at least two
contiguous leads on the standard 12-lead electrocardiogram
(ECG); and 3) a serum creatine kinase-MB (CK-MB)
fraction concentration of more than two times the upper
limit of the reference range (25 IU/liter in our laboratory) 6
to 12 h after admission. Excluded from the study were
patients who had significant valvular disease, revasculariza-
tion before echocardiography, post-infarction angina or
infarction complicated by severe hemodynamic instability,
uncontrolled hypertension, sustained ventricular tachycardia
or ventricular fibrillation occurring .24 h after admission,
pregnancy or a history of an adverse reaction to dobutamine,
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or if informed consent to participate in the study was
unobtainable.
On hospital admission, all patients were interviewed
regarding the timing of their most recent chest pains, if any.
Pre-infarction angina was defined as the presence of epi-
sodes of typical transient (,30 min) chest pain while
resting, in the 24 h before the onset of infarction. None of
our patients had chronic angina in the course of their
normal daily life activities. We selected a period of 24 h
because the beneficial effect of PIA appears to be the highest
when it occurs during this period (14). Some of our patients
were elderly and, as such, could be considered as suspect
with respect to the subjective assessment of their symptoms.
As suggested by Tombaugh and McIntyre (15) and Ives et
al. (16), the cognitive status of the patient could be a
confounding factor. Our group of patients appeared to be
cognitive regarding their chest pain at the time of admission
to the hospital, but because no specific test of dementia was
applied, it is theoretically possible that some patients may
have provided inappropriate information regarding their
type of chest pain.
The size of MI was assessed using the area under the
CK-MB curve method of Kloner et al. (1). Before the
patient was discharged from the hospital, the myocardial
inotropic reserve was evaluated with low-dose dobutamine
echocardiography (LDDE) by a member of the investigative
team who had no knowledge of the patients’ group assign-
ment. The protocol was performed according to Watada et
al. (17). Briefly, during continuous ECG monitoring, a
baseline echocardiogram, with the back-up of second har-
monic imaging, was obtained (parasternal long- and short-
axis views and apical four- and two-chamber views) and
transferred to a digital station. An intravenous infusion of
dobutamine was started at 5 mg/kg body weight per min and
continued for 6 min. Two-dimensional echocardiography
was repeated at the end of this stage, and again digitally
transferred. The dose of dobutamine was then increased to
10 mg/kg per min for another 6 min, and echocardiography
was repeated and digitally transferred. The transferred
images were analyzed relative to the baseline images. The
myocardial contractility reserve was evaluated at the 10-
mg/kg dose, unless myocardial ischemia was detected on the
echocardiogram, in which case, the evaluation was per-
formed at the 5-mg/kg dose. This protocol has a high
sensitivity, specificity and predictive value in detecting
improvement in regional wall motion (17). The left ventricle
was divided into 16 segments (18), and a semiquantitative
scoring system (1 5 normal; 2 5 hypokinesia; 3 5 akinesia;
4 5 dyskinesia) was used to analyze each echocardiogram
(19). Infarct zones were defined according to the theoretic
maximal risk area (18). The infarct zones of anterior,
inferior, posterior or lateral infarction consisted of nine
segments (apical inferior and apical lateral regions have
overlapping segments). An echocardiogram was considered
as technically inadequate if more than two segments could
not be clearly visualized.
We performed two different analyses of myocardial con-
tractility reserve: a segmental analysis and a patient analysis.
A segment was considered to have contractility reserve if we
could demonstrate an improvement of at least one grade in
the scoring, excluding those segments scoring 4. A patient
was considered to have significant myocardial contractility
reserve in the infarct zone if an improvement in contractility
occurred in at least two segments or in at least one segment
when only two segments were abnormal at baseline. Those
patients who had less than two segments with abnormal
contraction on the baseline echocardiogram were excluded
from the patient analysis, but not from the segmental
analysis.
Overall and regional wall motion score indexes (WMSI)
were derived from the baseline values and those obtained at
the dose of dobutamine used to evaluate myocardial ino-
tropic reserve (usually 10 mg/kg, except in one patient). The
values were calculated as the sum of the segment scores
divided by the number of segments scored (18).
All patients gave written, informed consent to participate,
after the investigational nature of the study had been
explained.
Data analysis. Continuous variables are expressed as the
mean value 6 SD, and categorical variables as absolute
numbers of patients, with percentages in parentheses.
Statistical analyses were performed by using the chi-
square or Fisher exact test for categorical variables and the t
test for continuous variables. If the variances between the
two groups were unequal (as assessed by the Levene test),
the Welch correction was applied. Differences were consid-
ered statistically significant at p , 0.05.
RESULTS
Originally, 130 patients were assessed in the study, 39 of
whom were subsequently excluded because of post-
infarction angina (n 5 15), death before the scheduled
echocardiogram (n 5 11), revascularization before the
scheduled echocardiogram (n 5 10), a technically inade-
quate echocardiogram (n 5 1) or their choice not to
participate in the study (n 5 2). Finally, 91 patients were
assessed; 29 (31.9%) of whom had PIA (PIA1).
Baseline characteristics. There were no differences in the
baseline characteristics between the groups (Table 1), but an
imbalance, albeit nonsignificant, was noted with respect to
Abbreviations and Acronyms
CK-MB 5 creatine kinase-MB fraction
ECG 5 electrocardiogram
LDDE 5 low-dose dobutamine echocardiography
MI 5 myocardial infarction
PIA 5 pre-infarction angina
PIA1 5 presence of pre-infarction angina
PIA2 5 absence of pre-infarction angina
WMSI 5 wall motion score index
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the higher prevalence of arterial hypertension and hyper-
cholesterolemia (35.5% vs. 17.2% and 40.3% vs. 20.7%,
respectively) in the group without PIA (PIA2) versus the
PIA1 group.
Characteristics and treatment of infarction. Primary cor-
onary angioplasty was the treatment in five patients with
PIA and in four patients without PIA. The extent of
myocardial injury, as assessed by the area under the CK-MB
curve, was lower in the PIA1 group (Table 2). The CK-MB
time curves are depicted in Figure 1. No significant differ-
ences were observed in the pharmacologic treatment of MI
in the first 24 h of infarction, except that the use of
abciximab was more frequent in the PIA1 group (1.6% vs.
13.8%, p 5 0.034).
Evaluation of myocardial viability. Dobutamine echocar-
diography was performed 6.4 6 2.2 days (range 2 to 20)
after the MI. This period allows for an assessment of the
presence (if any) of hibernating or stunned myocardium
after the infarction (i.e., viable segments with a higher
probability of recovery). The number of segments assessed
in infarct-related areas was 557 (99.8%) in the PIA2 group
and 256 (98.1%) in the PIA1 group. Although the percent-
age of segments with wall motion abnormalities was similar
in both groups (46.9% vs. 46.1%), the percentage of seg-
ments with inotropic reserve was significantly higher in the
PIA1 group (30.7% vs. 44.9%, p 5 0.007) (Table 3).
Excluding those patients with less than two segments that
scored 2 or 3, there were more patients with PIA who had
significantly greater myocardial viability, as compared with
patients without PIA (46.3% vs. 73.9%, p 5 0.026).
Although the WMSI values tended to be lower in PIA1
group than in the PIA2 group, the differences were not
statistically different.
DISCUSSION
As shown by the increased number of viable segments, this
study suggests that unstable angina preceding the onset of
an acute MI can preserve regional left ventricular wall
Table 1. Baseline Characteristics of Patients With Myocardial
Infarction With and Without Pre-Infarction Angina
PIA2 Group
(n 5 62)
PIA1 Group
(n 5 29)
p
Value
Age (yrs) 64 6 12 65 6 11 0.566
Females 7 (11.3%) 6 (20.7%) 0.232
Arterial hypertension 22 (35.5%) 5 (17.2%) 0.076
Diabetes mellitus 9 (14.5%) 4 (13.8%) 0.927
Hypercholesterolemia 25 (40.3%) 6 (20.7%) 0.066
Current smoker 27 (43.5%) 13 (44.8%) 0.909
Previous MI 6 (9.7%) 3 (10.3%) 1.000
Data are presented as the mean value 6 SD or number (%) of patients.
MI 5 myocardial infarction; PIA1 5 presence of pre-infarction angina; PIA2 5
absence of pre-infarction angina.
Table 2. Characteristics and Treatment of Patients With Acute Myocardial Infarction With and
Without Pre-Infarction Angina
PIA2 Group
(n 5 62)
PIA1 Group
(n 5 29)
p
Value
MI location, inferior/anterior 43/19 17/11 0.412
Delay since symptom onset (min)* 203 6 100 219 6 120 0.511
Primary PTCA 5 (8.1%) 4 (13.8%) 0.459
rt-PA/SK† 29/28 13/12 0.925
CK-MBmax (IU/liter) 269 6 158 227 6 125 0.217
MI size (U)‡ 182 6 127 140 6 68 0.049
Oral beta-blockers 11 (17.7%) 6 (20.7%) 0.736
Intravenous beta-blockers 8 (12.9%) 3 (10.3%) 1.000
Calcium antagonists 1 (1.6%) 0 1.000
Intravenous nitrates 37 (59.7%) 17 (58.6%) 0.924
ACE inhibitors 7 (11.3%) 3 (10.3%) 1.000
Unfractionated heparin 35 (56.5%) 17 (58.6%) 0.846
Antiplatelet drugs 61 (98.4%) 29 (100) 1.000
Diuretics 8 (12.9%) 2 (6.9%) 0.493
Dobutamine 3 (4.8%) 0 0.549
Abciximab 1 (1.6%) 4 (13.8%) 0.034
*Time to administration of fibrinolysis (or “to needle”). †Excluding those treated with primary angioplasty. ‡Variances unequal
(F 5 6.68, p 5 0.01), with Welch correction applied.
ACE 5 angiotensin-converting enzyme; CK-MBmax 5 maximal creatine kinase-MB fraction; MI 5 myocardial infarction;
PTCA 5 percutaneous transluminal coronary angioplasty; rt-PA 5 recombinant tissue plasminogen activator; SK 5
streptokinase; other abbreviations as in Table 1.
Figure 1. Time curves of creatine kinase-MB (CK-MB) in both groups.
Solid line 5 patients without pre-infarction angina (PIA); dashed line 5
patients with PIA. Error bars indicate the standard deviation.
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motion. Although the numbers of segments with wall
motion abnormalities on the baseline echocardiogram were
the same in patients with and without PIA, the percentage
of segments that conserve their inotropic reserve (as assessed
with LDDE) is significantly higher in patients with PIA.
The number of patients with significant viability is also
higher in this group. Hence, it is this group of patients that
benefits most from PIA (i.e., patients with a reperfused MI
[7,12,20] and those with episodes of PIA within a short
time of the onset of infarction [14]).
Pre-infarction angina and improvement in left ventricu-
lar function. This finding could explain the post-infarction
improvement in regional function observed in some studies
of patients with previous angina (9,10), because it is well
established that LDDE can predict the recovery of regional
function (17,18,21) after a reperfused MI. Noda et al. (10),
in patients with a reperfused anterior MI, observed an
increase in left ventricular function (as assessed by left
ventriculography) one month after infarction in patients
with previous angina (48 h before infarction). Similar results
were found by Nakagawa et al. (9) in patients with the same
characteristics, with left ventricular function immediately
after infarction similar in both groups. Ishihara et al. (7) and
Liuzzo et al. (8) did not find differences in left ventricular
function immediately after infarction in patients with and
without PIA, but they did not analyze regional wall motion
recovery, nor infarct-related myocardium viability. One
recently published study (12) found better left ventricular
function in patients with PIA. However, the results need to
be interpreted with caution, because the study had a
retrospective design in which ,40% of the patients had
received fibrinolytic treatment and the therapeutic dose used
was inappropriate. Similar findings were reported by Anzai
et al. (3), but in their study, the number of patients having
ventriculography performed before discharge from the hos-
pital was very small, and a selection bias cannot be ruled out.
These investigators also reported, using multiple logistic
regression analyses, that the absence of PIA was an inde-
pendent predictor of re-admission to the hospital for heart
failure and of cardiac mortality at one year (22). Although it
is not known whether this was due to variations in left
ventricular ejection fraction over the study period, it needs
to be noted that patients with anterior infarctions have a
lower incidence of aneurysm formation and a higher ejec-
tion fraction if they had PIA. Abete et al. (11) reported a
benefit induced by PIA only in patients ,65 years. Again,
the study was retrospective, and data on left ventricular
ejection fraction were available in ,30% of the patients
studied.
Influence of drug treatment. It is unlikely that the treat-
ment given in the acute phase of MI could have influenced
our findings, because all of our patients were treated either
with fibrinolysis or primary angioplasty, and no clinically
important differences were noted in the administration of
beta-blockers or nitrates. There were more patients with
PIA than without PIA who received abciximab, but because
the numbers were small, the differences observed could have
been due to chance alone.
Clinical implications. Our study could have important
clinical implications. Low-dose dobutamine echocardiogra-
phy has been used to predict recovery of dysfunctional
myocardium after revascularization (23–27) or after throm-
bolysis (17,18,20). Those patients with PIA have a higher
probability of viable myocardium in the infarct-related area,
and, as such, the beneficial effect of a revascularization
procedure could be higher if a flow-limiting coronary
stenosis exists (25). However, it is necessary to bear in mind
that segments of dysfunctional myocardium, but with signs
of viability, could have less post-revascularization improve-
ment than that predicted by contractile reserve with LDDE
(25,28). On the basis of this reasoning, it is possible that the
recovery of contractility of dysfunctional segments after
revascularization in the present study may have been over-
estimated. However, not all dysfunctional segments have a
flow-limiting coronary stenosis, and if viability is demon-
strated, a spontaneous recovery can occur (28).
We have demonstrated that PIA can preserve viability of
the left ventricular myocardium. If this mechanism could be
pharmaceutically mimicked, it would be a powerful tool to
conserve left ventricular function in the event of an acute
MI. Indeed, a drug such as this—nicorandil—is currently
available (29), and because it is a hybrid of adenosine
triphosphate-sensitive channel activators and the nitrates,
Table 3. Myocardial Inotropic Reserve in Patients With and Without Pre-Infarction Angina
PIA2 Group
(n 5 62)
PIA1 Group
(n 5 29)
p
Value
Segments with wall motion abnormalities* 261 (46.9%) 118 (46.1%) 0.899
Segments with inotropic reserve 80 (30.7%) 53 (44.9%) 0.007
Significant myocardial viability† 25 (46.3%) 17 (73.9%) 0.026
Basal WMSI (regional) 1.81 6 0.49 1.69 6 0.50 0.292
Dobutamine WMSI (regional) 1.63 6 0.55 1.44 6 0.46 0.103
Basal WMSI (global) 1.50 6 0.34 1.44 6 0.36 0.405
Dobutamine WMSI (global) 1.39 6 0.35 1.28 6 0.30 0.135
Delta index‡ 0.18 6 0.22 0.25 6 0.21 0.134
*With respect to the segments of the infarct zone. †Excluding those with less than two segments with wall motion abnormalities
(see text for details). ‡Basal WMSI (regional) minus dobutamine WMSI (regional).
WMSI 5 wall motion score index; other abbreviations as in Table 1.
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its proposed mode of action would appear more efficacious,
warranting further clinical evaluation.
Conclusions. Those patients who have unstable PIA and
who have a reperfused myocardium (either with fibrinolysis
or primary coronary angioplasty) after an acute MI have
more viable myocardial segments. This finding could ex-
plain the rapid recovery of regional and global left ventric-
ular function observed in this group of patients.
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